Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES PANACEA BIOTECH SUVEN LIFE SCIENCES/
PANACEA BIOTECH
 
P/E (TTM) x -20.5 -60.9 - View Chart
P/BV x 5.8 0.9 657.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUVEN LIFE SCIENCES   PANACEA BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
PANACEA BIOTECH
Mar-23
SUVEN LIFE SCIENCES/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs94191 49.0%   
Low Rs45107 42.0%   
Sales per share (Unadj.) Rs0.675.1 0.8%  
Earnings per share (Unadj.) Rs-5.4-5.5 98.4%  
Cash flow per share (Unadj.) Rs-5.10.9 -583.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.2137.7 12.5%  
Shares outstanding (eoy) m218.0761.25 356.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.0 5,622.8%   
Avg P/E ratio x-12.8-27.1 47.2%  
P/CF ratio (eoy) x-13.5170.0 -8.0%  
Price / Book Value ratio x4.01.1 372.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,1319,142 165.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1861,265 14.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1354,599 2.9%  
Other income Rs m84517 16.4%   
Total revenues Rs m2205,116 4.3%   
Gross profit Rs m-1,19647 -2,544.4%  
Depreciation Rs m65391 16.7%   
Interest Rs m544 12.1%   
Profit before tax Rs m-1,183128 -923.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0466 0.0%   
Profit after tax Rs m-1,183-337 350.5%  
Gross profit margin %-883.61.0 -86,436.9%  
Effective tax rate %0363.5 -0.0%   
Net profit margin %-873.5-7.3 11,906.3%  
BALANCE SHEET DATA
Current assets Rs m3,4555,623 61.4%   
Current liabilities Rs m1,0503,297 31.9%   
Net working cap to sales %1,776.050.6 3,512.1%  
Current ratio x3.31.7 192.9%  
Inventory Days Days3,94859 6,724.4%  
Debtors Days Days21848 456.4%  
Net fixed assets Rs m1,3737,028 19.5%   
Share capital Rs m21861 356.0%   
"Free" reserves Rs m3,5358,375 42.2%   
Net worth Rs m3,7538,436 44.5%   
Long term debt Rs m0202 0.0%   
Total assets Rs m4,82812,712 38.0%  
Interest coverage x-218.83.9 -5,631.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.4 7.8%   
Return on assets %-24.4-2.3 1,057.6%  
Return on equity %-31.5-4.0 787.8%  
Return on capital %-31.42.0 -1,571.4%  
Exports to sales %40.443.3 93.4%   
Imports to sales %839.824.4 3,437.7%   
Exports (fob) Rs m551,992 2.7%   
Imports (cif) Rs m1,1371,124 101.2%   
Fx inflow Rs m551,992 2.7%   
Fx outflow Rs m1,1371,191 95.5%   
Net fx Rs m-1,082801 -135.1%   
CASH FLOW
From Operations Rs m-1,031-4,225 24.4%  
From Investments Rs m-2,6064,303 -60.6%  
From Financial Activity Rs m3,955-184 -2,152.8%  
Net Cashflow Rs m317-105 -302.4%  

Share Holding

Indian Promoters % 69.6 73.6 94.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 1.0 57.9%  
FIIs % 0.5 0.3 207.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 26.4 115.2%  
Shareholders   74,003 47,091 157.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs Panacea Biotech Share Price Performance

Period Suven Life Sciences Panacea Biotech S&P BSE HEALTHCARE
1-Day 0.30% -1.74% 1.18%
1-Month -2.06% -20.01% -0.75%
1-Year 114.92% 11.75% 61.82%
3-Year CAGR 14.94% -12.26% 18.16%
5-Year CAGR -16.22% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.